The Effectiveness of Transdiagnostic Intervention and Mindfulness Based Schema Therapy on Patients with Breast Cancer

The Effectiveness of Transdiagnostic Intervention and Mindfulness Based Schema Therapy on Cancer Psychological Distress and Outcomes, Illness's Transdiagnostic Cognitive Processes and Cortisol Level in Patients with Breast Cancer

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210128050165N1

Enrollment

Registered

2021-06-26

Start date

2021-06-26

Completion date

Unknown

Last updated

2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer. Malignant neoplasm of breast

Interventions

Intervention 1: Intervention group: 2 groups, one will receive Transdiagnostic therapy and the other will receive Mindfulness based Schema therapy via internet. the period of each group therapy will b

Eligibility

Sex/Gender

Female

Age

30 Years to 60 Years

Inclusion criteria

Inclusion criteria: not using psychiatric drugs age between 30 to 60 education at least end of elementary school going under cancer therapy (except chemotherapy)

Exclusion criteria

Exclusion criteria: using psychiatric drugs or psychotherapies in the last 6 months absence in group therapy more than 2 sessions graduate from psychology major or related to that experienced trauma pressures or crisis in the grouptherapy for instance mourn

Design outcomes

Primary

Measure	Time frame
Cancer Psychological Outcomes. Timepoint: pretest, post test, follow up. Method of measurement: Impact Of Breast Cancer questionnaire, Cancer Survivors Resilience Scale, Breast Cancer Self-Efficacy Scale.;Psychological Distress. Timepoint: pretest, post test, follow up. Method of measurement: Psychological Impact of Cancer, Spiritual Distress Scale, Depression, Anxiety and Stress Scale-21.;Illness's Transdiagnostic Cognitive Processes. Timepoint: pretest, post test, follow up. Method of measurement: Acceptance and Action Questionnaire, Posttrumatic Avoidance Scale, Chronic illness-related cognitive fusion questionnaire, Rumination in response to illness scale.;Cortisol. Timepoint: pretest, post test. Method of measurement: blood sampling.	—

Measure

Time frame

Cancer Psychological Outcomes. Timepoint: pretest, post test, follow up. Method of measurement: Impact Of Breast Cancer questionnaire, Cancer Survivors Resilience Scale, Breast Cancer Self-Efficacy Scale.;Psychological Distress. Timepoint: pretest, post test, follow up. Method of measurement: Psychological Impact of Cancer, Spiritual Distress Scale, Depression, Anxiety and Stress Scale-21.;Illness's Transdiagnostic Cognitive Processes. Timepoint: pretest, post test, follow up. Method of measurement: Acceptance and Action Questionnaire, Posttrumatic Avoidance Scale, Chronic illness-related cognitive fusion questionnaire, Rumination in response to illness scale.;Cortisol. Timepoint: pretest, post test. Method of measurement: blood sampling.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Ghayour Kazemi

Azad University of Birjand, Mashhad Medicine University

fgkazemi@yahoo.com+98 51 3606 1093

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026